Ansell, Cochlear, Breville Shares Fall as US Tariffs Bite

Published on 04/02/2025 at 20:31 - Modified on 04/02/2025 at 20:32

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Cochlear Limited

Cochlear Limited Launches Smart Cochlear Implant System	Jul. 08	CI
Cochlear says co receives FDA approval for new Nucleus Nexa system	Jul. 07	RE
Cochlear Secures US FDA Approval for Smart Cochlear Implant System	Jul. 07	MT
UBS Upgrades Cochlear to Buy from Neutral, Price Target is AU$325	Jun. 18	MT
Cochlear Says It Launched New Cochlear Implant System	Jun. 11	RE
Cochlear Updates FY25 Earnings Guidance To A$390-400 Mln	Jun. 11	RE
Cochlear Cuts Guidance, Sees Fiscal Year 2025 Underlying Net Profit of Up to AU$400 Million	Jun. 11	MT
Cochlear Unveils Smart Cochlear Implant System	Jun. 11	MT
Australia shares cross 8,500 as oil lifts energy stocks; tech, healthcare shine	Jun. 03	RE
Cochlear Limited Introduces the Baha®? 7 Sound Processor and Baha SoundBand	Jun. 02	CI
Aussie shares end flat as miners offset healthcare stocks, Trump comments hit pharma stocks	May. 12	RE
Australian Shares Rise Amidst US-Japan Trade Exceptions Hopes; Guzman y Gomez Posts Higher Fiscal Q3 Sales	Apr. 08	MT
Cochlear Confirms Will Continue To Be Able To Rely On A Chapter Of Harmonized Tariff Schedule Of U.S.	Apr. 07	RE
Cochlear to Continue to Adopt Duty-Free Arrangement With US on Certain Products	Apr. 07	MT
Australian Shares Fall as Tariffs Cause Global Selloff; Fisher & Paykel Expects Higher Costs in Fiscal Year 2026	Apr. 03	MT
Cochlear Awaits Further Details on US Tariffs on Australian Imports	Apr. 02	MT
Ansell, Cochlear, Breville Shares Fall as US Tariffs Bite	Apr. 02	MT
Australian shares crash in Trump tariff meltdown	Apr. 02	RE
Cochlear Awaits Clarification On Application Of US Tariff	Apr. 02	RE
Cochlear's Fiscal H1 Miss Likely Due to Slowdown in Sales Ahead of New Sound Processor Model Launch, Citi Says	Mar. 05	MT
Steady rise in sales for Cochlear in 1HFY25	Feb. 18
Cochlear's Fiscal H1 Results Miss 'Disappointing,' Jarden Research Says	Feb. 16	MT
Jefferies Upgrades Cochlear to Buy from Hold; Price Target is AU$308	Feb. 14	MT
Australian Shares Flat on Trump Tariffs Delays; AMP Posts Lower 2024 Earnings Despite Rise in Revenue	Feb. 14	MT
Australia's Cochlear faces worst day in 5 years on weak earnings, forecast	Feb. 13	RE